Evolutionary digital twin framework for optimal aminoglycoside dosing in neonates with suspected sepsis. [PDF]
NPJ Digit MedPrunella M +8 more
europepmc +1 more source
Toxicity-guided dose modification for disseminated <i>Nocardia farcinica</i> brain abscess in a patient with pneumoconiosis: a brief research report. [PDF]
Front PharmacolLiu HJ, Wang LF, Li XY, Li L.
europepmc +1 more source
Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia. [PDF]
Int J MicrobiolBur R +7 more
europepmc +1 more source
Synergistic effects of meropenem, amikacin, and ciprofloxacin against carbapenem resistant Pseudomonas aeruginosa isolates. [PDF]
Sci RepFooladfar Z +6 more
europepmc +1 more source
Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes. [PDF]
J Antimicrob ChemotherCantón R +8 more
europepmc +1 more source
Inhaled amikacin as a preventive strategy against ventilator-associated pneumonia in a trauma intensive care unit: early evidence from a single-center retrospective cohort study. [PDF]
J Trauma InjKwon O +7 more
europepmc +1 more source
Related searches:
Amikacin, a semisynthetic analog of kanamycin, is very active against most gram-negative bacteria including gentamicin- and tobramycin-resistant strains. The effectiveness of amikacin in the treatment of serious gram-negative bacillary infections is well documented.
A M, Ristuccia, B A, Cunha
openaire +2 more sources